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INVITED COMMENT
Suprainguinal deep venous thrombosis and
pulmonary embolism—Common but often silent
Frank Padberg, Jr, MD, Newark, East Orange, and Lyons, NJ
The article by Borst-Krafek et al1 in the March issue of
the Journal of Vascular Surgery reminds readers that pul-
monary embolism (PE) occurs frequently with “proximal”
deep venous thrombosis (DVT). Inasmuch as therapeutic
decisions regarding DVT are largely driven by perceived
risk for embolism, the high incidence of PE (42%-51%)
reported in certain subsets of patients in this large study is of
considerable concern. The hypothesis that detectable ve-
nous thromboembolism (VTE) is more frequent or its
consequences more severe with more cephalad extent of
the primary extremity thrombus makes intuitive sense. As
the host vein increases in diameter, larger potential emboli
might be more likely to obstruct major pulmonary artery
segments. Therefore, if the incidence or severity of PE
varies according to its anatomic source, a proximal location
of DVT would increase its clinical significance.
In this study, 22% of thrombi thought to be located
above the inguinal ligament extended into the inferior vena
cava (IVC). However, symptoms and physical findings did
not delineate the location of the primary thrombus. For
those considering caval interruption, the indication for a
predeployment contrast study is reinforced by the reported
one chance in five of IVC extension. The 42% incidence of
PE with IVC thrombosis was lower than that for iliac (51%)
or femoral (50%) vein thrombosis, although the frequency
of PE was statistically indistinguishable among these ve-
nous segments. “Massive” PE was excluded from this se-
ries, and, on the basis of incomplete information, it is
presumed that most of the documented emboli were
asymptomatic. Accordingly, the observation that there was
no difference in incidence of symptomatic PE among the
patient groups may be tenuous.
An increasing volume of literature has confirmed the
clinical observation that infrapopliteal DVT (ie, tibial and
peroneal vein thrombosis) is associated with a compara-
tively low risk for embolism.2,3 The data presented by
Borst-Krafek and colleagues principally suggest that, al-
though PE is common, it occurs no more frequently with
suprainguinal DVT than with extensive thigh DVT. For the
purposes of this study, the term “proximal” has been rede-
fined to mean suprainguinal DVT. In general, the litera-
ture, including previous publications from these authors,
has assumed that proximal implies popliteal vein or higher,
thereby recognizing the differential risk for VTE between
calf vein thrombosis and popliteal vein thrombosis.2,4,5
Thus, as in this presentation, it is important for investiga-
tors to specify their definition of “proximal.”
This Viennese dermatology group has published regu-
larly on treatment of VTE, with specific interest in the
relationship of pelvic extension and PE.4,5 A feature of their
management algorithm is emphasis on compression and
early active ambulation, combined with heparin and oral
anticoagulation therapy.4,5 Because of the perceived inac-
curacy of duplex ultrasound scanning for diagnosis of su-
prainguinal thrombus, their previous contributions identi-
fied suprainguinal thrombosis with radionuclide
venography. These authors have adroitly addressed the
diagnosis of suprainguinal DVT in their present report with
magnetic resonance venography (MRV), a technique that is
reported to be as accurate as contrast-enhanced venography
and certainly is less invasive.6,7 Although MRV was com-
promised by frequent false-negative studies, current im-
provements in technique have largely resolved this concern.
In addition to improved visualization of suprainguinal
veins, MRV enables bilateral studies in a single examination
and provides images of nonaxial profunda and internal iliac
veins. Despite these considerations, duplex scanning re-
mains a valuable resource for routine practice, because
MRV requires approximately 50 minutes to perform and is
inappropriate for patients with claustrophobia or who have
metallic implants. Given the reported results, MRV is un-
likely to influence treatment (ie, thrombectomy, thrombol-
ysis, IVC filtration) in a similar population. Thus, outside of
a research protocol, it is not clear when clinicians should
consider requesting this expensive diagnostic investigation
if a duplex scan already suggests proximal extension.
The focus of this report is a cohort of 212 consecutive
patients in whom the diagnosis of suprainguinal DVT was
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made with duplex ultrasound scanning. This cohort was
culled from 1246 patients who received treatment of symp-
tomatic lower extremity DVT. Only 2 patients had phleg-
masia cerulea dolens, no thrombolysis or thrombectomy
was performed, no patients died, and no filters were placed
during 4 weeks of follow-up. Specifically excluded from the
study group were patients with massive PE (presumed class
3 or 4 disease with hemodynamic compromise), who would
have been admitted to the intensive care unit and not
followed up by the authors, and patients with DVT with no
evidence of suprainguinal extension at duplex ultrasound
scanning.1,8
Although internal referral patterns at the authors’ hos-
pital are not described, they state that “Nearly all pa-
tients...were first investigated in the department.” The
reader would like to assume that all iliofemoral DVTs were
treated consecutively by the authors, but the authors also
disclose that a “hospital-specific bias cannot be excluded.”
A previous manuscript addressing a similar topic notes
exclusion of patients who were seen in consultation by
members of the dermatology department but were “immo-
bilized in other departments because of surgery, trauma, or
internal organ dysfunction,” speculating that these patients
may represent a different population.4 Although it is not
specified that “immobilized” patients with VTE were not
included in their database, or referred to their hospital, it
would be difficult for these patients to comply with the
early mobilization specified in the treatment algorithm.
Therefore the reader is left to wonder whether these data
include immobilized, and often postsurgical, patients with
DVT.
No clinical differences in frequency of PE were encoun-
tered between patients with iliac thrombus alone, those
with IVC extension, and those with isolated femoral
thrombus in the study cohort. Nevertheless, selection of
the comparison group was not optimal. Because all of the
patients in the study cohort were thought to have DVT
extending into the pelvic veins, this comparison group
must be considered to have been preselected because they
had extensive femoral DVT. In the group with less exten-
sive femoral thrombus, from which this sample was derived,
pulmonary scans were not obtained routinely; for this rea-
son, the incidence of PE could not be compared directly
with a comparable figure in the study cohort. There is little
information to suggest that frequency of PE with infrain-
guinal DVT is lower than that above the inguinal ligament,
and a definite conclusion almost certainly would require
more thorough study of a tightly defined comparison
group consisting of only femoral or popliteal DVT. The
authors’ observations are interesting, but even they note
that the limited duration and compliance of their clinical
follow-up compromise substantive conclusions regarding
frequency of chronic extremity symptoms.
In summary, this experienced group has reported a
large series of VTE, which appears to confirm that proximal
DVT is associated with a high incidence of PE, a valuable
contribution irrespective of whether there actually is a
different incidence of PE between caval, pelvic, and femoral
DVT. Although the 42% incidence of PE with IVC throm-
bosis was the lowest of the three, it was not statistically
different from pelvic or femoral DVT. Management of
proximal DVT with the authors’ anticoagulant algorithm
for mobile patients resulted in a similar incidence of PE
regardless of the anatomic origin of DVT, but additional
data may be necessary before these results can be extrapo-
lated to immobilized patients with DVT.
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